Member Info for Bazzaman

There you go net, as I said you won't hear anything on Royalties until March 2026.

These MMs really are a joke, they have risen the SP all this week by the bear minimum and always below the ASX close. Gold falls by 1 per cent and they take the opportunity to drop the SP by 5%. They need your shares. Once the market closes in the UK, I reckon Gold will recover their price in the USA and then all we need is Shaun to drop the drilling results when Oz reopens and this SP will fly northwards again. Lots of good news to come this side of Christmas so don't let the crooks steal your shares on the cheap. GLA

Net, we will get more details in November on the full year results (as at 30th June) which came in the August trading update but don't expect anything on royalties.

AI has updated its position on the NDA as follows;

NDA with Croda

Licensing and commercialization: SkinBioTherapeutics has partnered with Croda to commercialize its Zenakine™ technology. The NDA is a key part of this agreement, which has been a major focus for investors.

"NDA saga": Some sources refer to a "saga" or "dialogue" surrounding the NDA with Croda, implying a period of negotiation, potential challenges, and uncertainty about its outcome.

Commercial success: Recent reports suggest that the commercial launch is progressing well, and that Zenakine™ is not a failure but rather the early stages of a commercial success story, partly due to a strong partnership with Croda.

Improved technology: Zenakine™ is described as an "evolutionary" technology that builds on the legacy of Matrixyl, offering clinically proven performance.

Commercial transition: The company has outlined a strategy to transition from Matrixyl to Zenakine™, including offering both products during a transition period and providing co-branded technical packs to help formulators.

Investor sentiment: While there was some initial frustration about the company's silence on the royalty figures for the Zenakine™/Croda agreement, recent reports indicate a shift in investor sentiment, with some now viewing the deal as a quiet success story.

This suggests that we have zero chance of hearing anything on Royalties until the half-year results in March 2026 and as such the SP will continue moving sideways until then. So much for the £1 by Christmas hey Dustbin, oh wait you said Christmas 2024. Maybe you have now changed your mind until Christmas 2026.

GLA

Dustbin, your timeline increases every time you post. Any chance the SP will be above 17p before the big vote? Might determine Ashman's future if it isn't. Not tool long to wait.

Hi Toyin, agree with you. Nobody has ever said they hate Ashman, he is just a poor performer who constantly gets it wrong. Dustbin just ramps. Have a nice day.

Must have been staged in Newcastle where the post it notes were circulated recently, looks that way to me.

Two boxes of each on the shelf, interesting..............

Axisbiotix are showing an Instagram video with the product in one of the Superdrug stores in an unknown shopping centre with a shopper selecting the boxes and purchasing them. The products didn't seem to be in an eye catching part of the store and didn't seem to have psoriasis or acne on them. However, looks like they do exist in at least one store which makes a mockery of Ashman's excuse yesterday on the shelf wobblers. Is he paying attention.

Dustbin, so your answer is no then?

Dustbin, are you expecting either SBTX or Ashman to get any mention/credit during the Zenakine presentation tomorrow?

Oh dear Ray, hit a raw nerve did I. Trot along poodle.

Elrico, the only person frightening investors is Ashman, he doesn't have a clue. His position is becoming untenable, can never give a straight answer that anybody believes. I do not give myself any credence for investors to take their share buying/selling because of what I say, I think you are barking up the wrong tree.

I wonder how the big 5 feel about supporting his last placing at 17p which let's face it was partly to hide the performance of his acquisitions which have been dire. Croda update tomorrow whereby I have no confidence in them mentioning SBTX at all. Yes, an update on Zenakine but anything on Royalties, forget it. 2025 which should have been so great for this company has turned into a complete shambles and of course his supporters (which have been a bit quiet lately) will say no worries 2026 is the future and nearby and we will make shedloads from the Royalties. Maybe, buy Croda must be looking at how poor this company is run and know that they could take it out for next to nothing in the grand scheme of things. I also think that Ashman would jump at the chance. Royalties sound great on paper but none of us know anything about them yet.

it is absolutely critical that the ceo of any company prioritises the performance of all aspects of running the company. unfortunately we have one who is totally incompetent and has been for the past 6 years who couldn't even run a **** up in a brewery. time to resign ashman, you just don't have a clue.

The selling continues at 13.75p now, wakey wakey Ashman time for you to resign.

The clown is out of his depth, he doesn't understand the market and has nobody in the company who does. Good job Croda only give him one simple task to do. He cant communicate and when he does try he uses all the wrong words, imminent, really!!

Doesn't look like the income stream from Superdrug was ever imminent on 6th October RNS and who forgot to sort out the shelf wobblers then, it's not rocket science for a store is it. Another screw up, already 5 weeks late how much longer before it gets fixed then? No idea obviously.

Another weak Ashman excuse, missing marketing material oh dear it's never his fault.

In the meantime the SP flounders from his lack of communication, 13p anyone?

No surprise there, but as Ashman said it's imminent. He really doesn't have a clue.